| Oct 12 |
With 60% institutional ownership, Australian Clinical Labs Limited (ASX:ACL) is a favorite amongst the big guns
|
| Sep 21 |
Why Australian Clinical Labs Limited (ASX:ACL) Could Be Worth Watching
|
| Aug 31 |
We Wouldn't Be Too Quick To Buy Australian Clinical Labs Limited (ASX:ACL) Before It Goes Ex-Dividend
|
| Aug 29 |
Australian Clinical Labs Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 26 |
Do Its Financials Have Any Role To Play In Driving Australian Clinical Labs Limited's (ASX:ACL) Stock Up Recently?
|
| Jul 16 |
Top ASX Stocks Estimated To Be Undervalued In July 2024
|
| Jul 1 |
Top ASX Stocks Estimated as Undervalued for Investment Opportunities in July 2024
|
| Jul 1 |
Australian Clinical Labs Limited's (ASX:ACL) Intrinsic Value Is Potentially 85% Above Its Share Price
|
